Skip to main content

Lucid Diagnostics Inc.

For the period ended Dec 31, 2025. Filed Mar 25, 2026.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Mar 25, 2026

LUCD$0.42+4.9%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Consolidated Balance Sheets

​ · ​ · December 31, 2025 · ​ · ​ · December 31, 2024 · ​
Assets:​​​​​​​​
Current assets:​​​​​​​​
Cash​$34,705​​$22,358​
Accounts receivable​​643​​​45​
Inventory​​353​​​341​
Prepaid expenses, deposits, and other current assets​​1,767​​​2,404​
Total current assets​​37,468​​​25,148​
Fixed assets, net​​809​​​1,062​
Operating lease right-of-use assets​​1,806​​​2,637​
Intangible assets, net​​315​​​736​
Other assets​​47​​​1,132​
Total assets​$40,445​​$30,715​
Liabilities, Preferred Stock and Stockholders’ Equity (Deficit)​​​​​​​​
Current liabilities:​​​​​​​​
Accounts payable​$970​​$1,241​
Accrued expenses and other current liabilities​​2,719​​​2,829​
Operating lease liabilities, current portion​​893​​​854​
Senior Secured Convertible Notes - at fair value​​24,000​​​18,600​
Total current liabilities​​28,582​​​23,524​
Operating lease liabilities, less current portion​​927​​​1,800​
Total liabilities​​29,509​​​25,324​
Commitments and contingencies (Note 11)​​​​​​​​
Stockholders’ Equity:​​​​​​​​
Preferred stock, $0.001 par value, 20,000,000 shares authorized; Series B and Series B-1 Convertible Preferred Stock, issued and outstanding 54,274 and 54,419 as of December 31, 2025 and December 31, 2024, respectively​​54,274​​​54,419​
Common stock, $0.001 par value, 300,000,000 shares authorized as of December 31, 2025 and December 31, 2024, respectively; 131,098,762 and 63,071,950 shares issued and outstanding as of December 31, 2025 and December 31, 2024, respectively​​131​​​63​
Additional paid-in capital​​230,866​​​154,675​
Accumulated deficit​​(274,335)​​(203,766)
Total Stockholders’ Equity (Deficit)​​10,936​​​5,391​
Total Liabilities and Stockholders’ Equity (Deficit)​$40,445​​$30,715​
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.